As of 2026-10-12, the Relative Valuation of Bio Rad Laboratories Inc (BIO) is 604.24 USD. This relative valuation is based on P/E multiples. With the latest stock price at 366.16 USD, the upside of Bio Rad Laboratories Inc based on Relative Valuation is 65.0%.
The range of the Relative Valuation is 285.56 - 963.56 USD.
| Range | Selected | |
| Trailing P/E multiples | 34.4x - 36.9x | 34.8x |
| Forward P/E multiples | 28.1x - 31.5x | 30.0x |
| Fair Price | 285.56 - 963.56 | 604.24 |
| Upside | -22.0% - 163.2% | 65.0% |
| Date | P/E |
| 2026-10-09 | 44.06 |
| 2026-10-08 | 43.36 |
| 2026-10-07 | 44.27 |
| 2026-10-06 | 44.38 |
| 2026-10-05 | 45.70 |
| 2026-10-02 | 44.42 |
| 2026-10-01 | 42.78 |
| 2026-09-30 | 45.45 |
| 2026-09-29 | 45.67 |
| 2026-09-28 | 45.45 |
| 2026-09-25 | 45.84 |
| 2026-09-24 | 46.63 |
| 2026-09-23 | 45.59 |
| 2026-09-22 | 45.67 |
| 2026-09-21 | 45.40 |
| 2026-09-18 | 45.29 |
| 2026-09-17 | 46.01 |
| 2026-09-16 | 45.61 |
| 2026-09-15 | 45.48 |
| 2026-09-14 | 44.35 |
| 2026-09-11 | 44.44 |
| 2026-09-10 | 44.37 |
| 2026-09-09 | 45.36 |
| 2026-09-08 | 45.74 |
| 2026-09-04 | 46.46 |
| 2026-09-03 | 46.67 |
| 2026-09-02 | 46.75 |
| 2026-09-01 | 45.84 |
| 2026-08-31 | 46.46 |
| 2026-08-28 | 46.65 |
| 2026-08-27 | 46.92 |
| 2026-08-26 | 46.76 |
| 2026-08-25 | 46.97 |
| 2026-08-24 | 45.93 |
| 2026-08-21 | 45.73 |
| 2026-08-20 | 45.30 |
| 2026-08-19 | 43.83 |
| 2026-08-18 | 42.44 |
| 2026-08-17 | 42.74 |
| 2026-08-14 | 42.87 |
| 2026-08-13 | 43.46 |
| 2026-08-12 | 43.57 |
| 2026-08-11 | 42.87 |
| 2026-08-10 | 42.66 |
| 2026-08-07 | 42.41 |
| 2026-08-06 | 41.20 |
| 2026-08-05 | 41.86 |
| 2026-08-04 | 40.05 |
| 2026-08-03 | 40.27 |
| 2026-07-31 | 39.16 |